(NASDAQ: IDYA) Ideaya Biosciences's forecast annual revenue growth rate of -28.36% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 99.61%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.58%.
Ideaya Biosciences's revenue in 2025 is $214,834,000.On average, 21 Wall Street analysts forecast IDYA's revenue for 2025 to be $15,555,527,436, with the lowest IDYA revenue forecast at $859,130,798, and the highest IDYA revenue forecast at $25,313,675,310. On average, 21 Wall Street analysts forecast IDYA's revenue for 2026 to be $4,576,712,496, with the lowest IDYA revenue forecast at $0, and the highest IDYA revenue forecast at $15,459,971,051.
In 2027, IDYA is forecast to generate $10,216,643,188 in revenue, with the lowest revenue forecast at $5,240,697,870 and the highest revenue forecast at $17,340,415,502.